Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
162.35
157.11
123.44
111.05
111.48
115.68
84.41
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
162.35
157.11
123.44
111.05
111.48
115.68
84.41
Raw Material Cost
85.34
79.68
57.11
54.05
49.98
52.29
36.79
Purchase of Finished goods
0.47
6.03
2.32
1.02
7.98
6.50
1.93
(Increase) / Decrease In Stocks
1.62
0.97
-0.32
-0.44
0.07
2.01
0.02
Employee Cost
14.74
14.22
14.36
13.31
12.15
12.68
11.07
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
-0.01
-0.01
0.00
-0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
19.17
17.46
20.03
17.77
17.13
16.31
17.11
Total Expenditure (Excl Depreciation)
121.34
118.36
93.49
85.70
87.31
89.78
66.91
Operating Profit (PBDIT) excl Other Income
41.01
38.75
29.95
25.35
24.17
25.90
17.50
Other Income
0.62
1.06
0.53
0.90
0.38
0.77
0.65
Operating Profit (PBDIT)
41.63
39.81
30.48
26.25
24.55
26.67
18.15
Interest
2.66
2.89
2.48
2.84
2.76
2.49
2.20
Exceptional Items
0.00
0.00
-0.83
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
38.97
36.92
27.17
23.41
21.79
24.18
15.95
Depreciation
4.99
5.26
4.82
4.96
4.76
5.09
4.56
Profit Before Tax
33.99
31.67
22.35
18.45
17.03
19.07
11.39
Tax
8.36
6.36
6.35
4.33
5.11
4.59
2.87
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
25.62
25.31
16.00
14.12
11.92
14.48
8.52
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
25.62
25.31
16.00
14.12
11.92
14.48
8.52
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.01
-0.01
0.00
-0.01
-0.01
-0.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
25.62
25.30
16.01
14.12
11.93
14.49
8.53
Equity Capital
10.38
10.38
10.38
10.38
10.38
10.38
10.38
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
24.68
24.37
15.42
13.6
11.49
13.96
8.22
Diluted Earnings per share
24.69
24.39
15.42
13.6
11.49
13.95
8.21
Operating Profit Margin (Excl OI)
25.26%
24.66%
24.26%
22.83%
21.68%
22.39%
20.73%
Gross Profit Margin
24.0%
23.5%
22.01%
21.08%
19.55%
20.9%
18.9%
PAT Margin
15.78%
16.11%
12.96%
12.71%
10.69%
12.52%
10.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 45.63% vs 39.21% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 114.75% vs 42.70% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 69.67% vs 39.31% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -3.62% vs 11.29% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Kwality Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
162.35
125.55
36.80
29.31%
Other Operating Income
0.00
0.00
0.00
Total Operating income
162.35
125.55
36.80
29.31%
Raw Material Cost
85.34
50.22
35.12
69.93%
Purchase of Finished goods
0.47
0.00
0.47
(Increase) / Decrease In Stocks
1.62
4.30
-2.68
-62.33%
Employee Cost
14.74
20.40
-5.66
-27.75%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
19.17
23.26
-4.09
-17.58%
Total Expenditure (Excl Depreciation)
121.34
98.18
23.16
23.59%
Operating Profit (PBDIT) excl Other Income
41.01
27.37
13.64
49.84%
Other Income
0.62
1.58
-0.96
-60.76%
Operating Profit (PBDIT)
41.63
28.95
12.68
43.80%
Interest
2.66
2.56
0.10
3.91%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
38.97
26.39
12.58
47.67%
Depreciation
4.99
4.35
0.64
14.71%
Profit Before Tax
33.99
22.04
11.95
54.22%
Tax
8.36
5.56
2.80
50.36%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
25.62
16.49
9.13
55.37%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
25.62
16.49
9.13
55.37%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.68
-0.68
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
25.62
15.80
9.82
62.15%
Equity Capital
10.38
11.09
-0.71
-6.40%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
24.68
14.25
10.43
73.19%
Diluted Earnings per share
24.69
14.78
9.91
67.05%
Operating Profit Margin (Excl OI)
25.26%
21.80%
0.00
3.46%
Gross Profit Margin
24.00%
21.02%
0.00
2.98%
PAT Margin
15.78%
13.13%
0.00
2.65%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 162.35 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is 3.34% vs 27.28% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 45.63% vs 39.21% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 25.62 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is 1.26% vs 58.03% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 114.75% vs 42.70% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 41.01 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is 5.83% vs 29.38% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 69.67% vs 39.31% in Jun 2025
Quarterly - Interest
Interest 2.66 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is -7.96% vs 16.53% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -3.62% vs 11.29% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.26%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
